Evidence map›Paper›PMID 39307720›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study].

X Z Liu, S J Zhou, J Huang, C F Zhao, L X Jiang, Y D Zhang, C Mei, L Y Ma, X P Zhou, Y P Shao and 27 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

X Z LiuDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
S J ZhouDepartment of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
J HuangDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Department of Hematology, the Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China.
C F ZhaoDepartment of Hematology, Jinhua Municipal Central Hospital, Jinhua 321000, China.
L X JiangDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Y D ZhangDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
C MeiDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
L Y MaDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
X P ZhouDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Y P ShaoDepartment of Hematology, Taizhou Hospital, Taizhou 317000, China.
G Q WuDepartment of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang 322100, China.
X B XiaoDepartment of Hematology, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou 310009, China.
R X YaoDepartment of Hematology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
X H DuDepartment of Hematology, Ningbo Yinzhou People's Hospital, Ningbo 315040, China.
T L HuDepartment of Hematology, Zhejiang Provincial Hospital of TCM, Hangzhou 310006, China.
S X QianDepartment of Hematology, Hangzhou First People's Hospital, Hangzhou 310006, China.
Y LiDepartment of Hematology, First Hospital of Jiaxing, Jiaxing 314001, China.
X F YanDepartment of Hematology, Quzhou People's Hospital, Quzhou 324000, China.
L HuangDepartment of Hematology, Jinhua People's Hospital, Jinhua 321000, China.
M L WangDepartment of Hematology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
J P FuDepartment of Hematology, Shaoxing People's Hospital, Shaoxing 312000, China.
L H ShouDepartment of Hematology, Huzhou Central Hospital, Huzhou 313000, China.
W H JiangDepartment of Hematology, Taizhou First People's Hospital, Taizhou 318020, China.
W M JinDepartment of Hematology, Lishui Municipal People Hospital, Lishui 323000, China.
L J LiDepartment of Hematology, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
J LeDepartment of Hematology, Li Huili Hospital, Ningbo 315040, China.
W J LuoDepartment of Hematology, The First People's Hospital of Xiaoshan District, Hangzhou 311200, China.
Y ZhangDepartment of Hematology, Yueqing People's Hospital, Wenzhou 325600, China.
X J ZhouDepartment of Hematology, Haining People's Hospital, Haining 314400, China.
H ZhangDepartment of Hematology, The Third Affiliated Hospital of Wenzhou Medical University, Rui'an 325200, China.
X H LangDepartment of Hematology, Yongkang First People's Hospital, Yongkang 321300, China.
M ZhouDepartment of Hematology, Zhuji People's Hospital, Zhuji 311800, China.
J JinDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
H F JiangDepartment of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou 310012, China.
J ZhangDepartment of Hematology, Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou 310016, China.
G F OuyangDepartment of Hematology, The First Affiliated Hospital of Ningbo University School of Medicine, Ningbo 315010, China.
H Y TongDepartment of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Funding

National Natural Science Foundation of China 82270146
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myelodysplastic SyndromesAdolescentAdultAgedAged, 80 and overAzacitidineFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeYoung AdultAzacitidineAzacitidineDecitabineHypomethylating agentsMyelodysplastic syndromesPrognosis

Identifiers

PMID39307720
PMCPMC11535563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.